Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-02-20 @ 8:07 PM
Study NCT ID:
NCT00089869
Status:
COMPLETED
Last Update Posted:
2006-07-20
First Post:
2004-08-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D012559', 'term': 'Schizophrenia'}], 'ancestors': [{'id': 'D019967', 'term': 'Schizophrenia Spectrum and Other Psychotic Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000077152', 'term': 'Olanzapine'}, {'id': 'D000069445', 'term': 'Atomoxetine Hydrochloride'}], 'ancestors': [{'id': 'D001569', 'term': 'Benzodiazepines'}, {'id': 'D001552', 'term': 'Benzazepines'}, {'id': 'D006574', 'term': 'Heterocyclic Compounds, 2-Ring'}, {'id': 'D000072471', 'term': 'Heterocyclic Compounds, Fused-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D011437', 'term': 'Propylamines'}, {'id': 'D000588', 'term': 'Amines'}, {'id': 'D009930', 'term': 'Organic Chemicals'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE1', 'PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'primaryPurpose': 'TREATMENT'}}, 'statusModule': {'overallStatus': 'COMPLETED', 'statusVerifiedDate': '2006-07', 'lastUpdateSubmitDate': '2006-07-18', 'studyFirstSubmitDate': '2004-08-16', 'studyFirstSubmitQcDate': '2004-08-17', 'lastUpdatePostDateStruct': {'date': '2006-07-20', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2004-08-18', 'type': 'ESTIMATED'}}, 'conditionsModule': {'conditions': ['Schizophrenia']}, 'descriptionModule': {'briefSummary': 'Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '55 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Must have a clinical diagnosis of Schizophrenia\n* Must be at least 18 years of age and not older than 55 years of age\n* Must have been stable on a dose of Abilify, Risperdal, Seroquel, or Zyprexa for the past 8 weeks\n* Women of childbearing potential must be using a medically accepted means of contraception\n* Must be able to swallow capsules\n\nExclusion Criteria:\n\n* Has serious health problems other than Schizophrenia\n* Takes an antidepressant for depression\n* Takes insulin for diabetes\n* Have a history of alcohol or drug dependence (except for nicotine and caffeine) within the past 6 months'}, 'identificationModule': {'nctId': 'NCT00089869', 'briefTitle': 'A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia', 'organization': {'class': 'INDUSTRY', 'fullName': 'Eli Lilly and Company'}, 'orgStudyIdInfo': {'id': '8269'}, 'secondaryIdInfos': [{'id': 'H6U-MC-HGLM'}]}, 'armsInterventionsModule': {'interventions': [{'name': 'olanzapine', 'type': 'DRUG'}, {'name': 'atomoxetine', 'type': 'DRUG'}, {'name': 'placebo', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'city': 'Cerritos', 'state': 'California', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 33.85835, 'lon': -118.06479}}, {'city': 'Chula Vista', 'state': 'California', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician.', 'geoPoint': {'lat': 32.64005, 'lon': -117.0842}}, {'city': 'Garden Grove', 'state': 'California', 'country': 'United States', 'facility': 'For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.', 'geoPoint': {'lat': 33.77391, 'lon': -117.94145}}, {'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'city': 'New Haven', 'state': 'Connecticut', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 41.30815, 'lon': -72.92816}}, {'city': 'New Haven', 'state': 'Connecticut', 'country': 'United States', 'facility': 'For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.', 'geoPoint': {'lat': 41.30815, 'lon': -72.92816}}, {'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'city': 'Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'city': 'Indianapolis', 'state': 'Indiana', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 39.76838, 'lon': -86.15804}}, {'city': 'Iowa City', 'state': 'Iowa', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 41.66113, 'lon': -91.53017}}, {'city': 'Minneapolis', 'state': 'Minnesota', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 44.97997, 'lon': -93.26384}}, {'city': 'Lebanon', 'state': 'New Hampshire', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 43.64229, 'lon': -72.25176}}, {'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'city': 'Butner', 'state': 'North Carolina', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 36.13209, 'lon': -78.75667}}, {'city': 'Chapel Hill', 'state': 'North Carolina', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 35.9132, 'lon': -79.05584}}, {'city': 'Okalahoma City', 'state': 'Oklahoma', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."'}, {'city': 'Austin', 'state': 'Texas', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 30.26715, 'lon': -97.74306}}, {'city': 'Irving', 'state': 'Texas', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 32.81402, 'lon': -96.94889}}, {'city': 'Irving', 'state': 'Texas', 'country': 'United States', 'facility': 'For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.', 'geoPoint': {'lat': 32.81402, 'lon': -96.94889}}, {'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': '"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Eli Lilly and Company', 'class': 'INDUSTRY'}}}}